Charles River Laboratories | CRL - Equity Capital And Reserves

Stock Price
183.70
Daily Change
-17.92 -8.89%
Monthly
-15.00%
Yearly
10.48%
Q1 Forecast
204.00

Charles River Laboratories reported $3.41B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Agilent USD 6.74B 371M Sep/2025
Align Technology USD 3.96B 44.68M Sep/2025
Bio-Rad Laboratories USD 6.74B 391.9M Sep/2025
Bruker USD 2.49B 625.6M Sep/2025
Cardinal Health USD -2.88B 5M Dec/2025
Charles River Laboratories USD 3.41B 52.13M Sep/2025
Cigna USD 41.8B 1.38B Sep/2025
CVS Health USD 72.93B 4.45B Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.48B 482M Sep/2025
Elevance Health USD 44.03B 73M Dec/2025
Galapagos EUR 2.45B 196.86M Sep/2025
Hologic USD 5.25B 197.2M Dec/2025
Humana USD 18.52B 227M Sep/2025
Illumina USD 2.38B 123M Sep/2025
Incyte USD 4.65B 480.29M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Laboratory Of America USD 8.71B 240.3M Sep/2025
Lonza CHF 9.33B 23M Dec/2024
McKesson USD -1.3B 441M Dec/2025
Merck EUR 28.94B 677M Sep/2025
Mettler Toledo International USD -249.2M 9.59M Sep/2025
Novartis USD 44.75B 2.7B Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Quest Diagnostics USD 7.26B 30M Sep/2025
Revvity USD 7.38B 180.27M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
United Therapeutics USD 6.59B 583.4M Sep/2025
UnitedHealth USD 105.81B 1.03B Sep/2025
Waters USD 2.33B 170.88M Sep/2025
West Pharmaceutical Services USD 3.05B 122.4M Sep/2025